HomeTherapeutic validation of GEF-H1 using a de novo designed inhibitor in models of retinal disease June 13, 2022 print this article Therapeutic validation of GEF-H1 using a de novo designed inhibitor in models of retinal disease Mills et al.; Cells. 2022 May 24;11(11):1733